Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruko Yamamoto

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
JAMA Network Open|June 8, 2026
Public Acceptance of Emergency Research Without Prior Consent in StrokeMasaru Suzuki, Mayumi Fukuda-Doi, Haruko Yamamoto, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 6, 2008
Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute strokeHiroyuki Kawano, Kazunori Toyoda, Shigeki Miyata, et al.
Cardiovascular Drugs and Therapy|May 24, 2020
"BAX602" in Preventing Surgical Adhesion after Extracorporeal Ventricular Assist Device Implantation for Refractory Congestive Heart Failure: Study Protocol for a Multicenter Randomized Clinical TrialSatsuki Fukushima, Koko Asakura, Toshimitsu Hamasaki, et al.
Genes|October 23, 2021
Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese PatientsTomotaka Tanaka, Masafumi Ihara, Kazuki Fukuma, et al.
Journal of the American Heart Association|August 13, 2021
Effect of Heart Rate Variabilities on Outcome After Acute Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH-2Kaori Miwa, Masatoshi Koga, Mayumi Fukuda-Doi, et al.
Annals of Nuclear Medicine|December 14, 2004
Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: factors influencing the quantitative resultsYujiro Seike, Kazuo Hashikawa, Naohiko Oku, et al.
Cardiovascular Drugs and Therapy|June 28, 2018
Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical TrialNorihide Fukushima, Eisuke Tatsumi, Osamu Seguchi, et al.
Cardiovascular Drugs and Therapy|June 24, 2024
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV TrialChisato Izumi, Masashi Amano, Satsuki Fukushima, et al.
Circulation Reports|March 19, 2021
Pediatric Medical Devices - Survey of Pediatric Cardiologists and Cardiovascular Surgeons in JapanTakekazu Miyoshi, Atsuko Kato, Satoshi Yasukochi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 12, 2020
Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 TrialShuhei Okazaki, Haruko Yamamoto, Lydia D Foster, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
JAMA Network Open|June 8, 2026
Public Acceptance of Emergency Research Without Prior Consent in StrokeMasaru Suzuki, Mayumi Fukuda-Doi, Haruko Yamamoto, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 6, 2008
Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute strokeHiroyuki Kawano, Kazunori Toyoda, Shigeki Miyata, et al.
Cardiovascular Drugs and Therapy|May 24, 2020
"BAX602" in Preventing Surgical Adhesion after Extracorporeal Ventricular Assist Device Implantation for Refractory Congestive Heart Failure: Study Protocol for a Multicenter Randomized Clinical TrialSatsuki Fukushima, Koko Asakura, Toshimitsu Hamasaki, et al.
Genes|October 23, 2021
Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese PatientsTomotaka Tanaka, Masafumi Ihara, Kazuki Fukuma, et al.
Journal of the American Heart Association|August 13, 2021
Effect of Heart Rate Variabilities on Outcome After Acute Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH-2Kaori Miwa, Masatoshi Koga, Mayumi Fukuda-Doi, et al.
Annals of Nuclear Medicine|December 14, 2004
Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: factors influencing the quantitative resultsYujiro Seike, Kazuo Hashikawa, Naohiko Oku, et al.
Cardiovascular Drugs and Therapy|June 28, 2018
Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical TrialNorihide Fukushima, Eisuke Tatsumi, Osamu Seguchi, et al.
Cardiovascular Drugs and Therapy|June 24, 2024
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV TrialChisato Izumi, Masashi Amano, Satsuki Fukushima, et al.
Circulation Reports|March 19, 2021
Pediatric Medical Devices - Survey of Pediatric Cardiologists and Cardiovascular Surgeons in JapanTakekazu Miyoshi, Atsuko Kato, Satoshi Yasukochi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 12, 2020
Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 TrialShuhei Okazaki, Haruko Yamamoto, Lydia D Foster, et al.
Pageof 8